Future Interventional Oncology Catheter-Based Therapies
- 1 September 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 01 (03) , 225-232
Abstract
Minimally invasive techniques in the treatment of cancer continue to develop at a rapid pace. Although surgical resection currently remains the only option for a complete cure, not all diseases are amenable to complete removal. This leaves opportunities to develop effective downstaging techniques as well as palliative care. In the realm of minimally invasive oncologic techniques, catheter-based therapies are an attractive option because malignancies require a blood supply to remain active. The intra-arterial (IA) delivery of specific tumoricidal drugs has been shown to be a successful delivery method in a variety of different cancers, and it is currently a progressive area of research. There is work both to increase the delivery specificity of oncologic drugs, including SW43 sigma receptor ligand and nanoparticle research. In addition, oncolytic viral therapy and 3-bromopyruvate have become increasingly more attractive tumoricidal drug prospects. In the future, the success of these therapies will ultimately determine the degree to which IA delivery will compete with the systemic delivery of drugs in the treatment of cancer.Keywords
This publication has 57 references indexed in Scilit:
- Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat modelBMC Research Notes, 2013
- Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase AntagonistsRadiology, 2012
- Nanoparticles Labeled with Positron Emitting Nuclides: Advantages, Methods, and ApplicationsBioconjugate Chemistry, 2012
- Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastomaNeuro-Oncology, 2012
- Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding siteNature Communications, 2011
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses CollideMolecular Therapy, 2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Targeting of VX2 Rabbit Liver Tumor by Selective Delivery of 3-Bromopyruvate: A Biodistribution and Survival StudyThe Journal of Pharmacology and Experimental Therapeutics, 2008
- On the Origin of Cancer CellsScience, 1956